ArticleMolecular and cellular pediatrics2026
Real-world impact of nirsevimab on RSV hospitalizations in children under 2 years of age: retrospective monocentric study in a large German tertiary pedatric center.
Moritz Bauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.